Pregnancy Category: C
No clinical study has been conducted in pregnant or lactating women. Animal studies do not indicate harmful effects to embryonal/fetal development, parturition, or postnatal development. Ticagrelor should be used during pregnancy only if the potential benefit to the mother justifies any potential risks to the fetus.
It is not known whether Ticagrelor can be secreted into the human milk. Animal studies have shown that ticagrelor and active metabolites are excreted in the milk. The use of Ticagrelor to lactating women is not recommended.
Other Services
Country
Account